Vitamin D and COVID-19

Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while a...

Full description

Saved in:
Bibliographic Details
Published in:Hormones (Athens, Greece) Greece), 2021-03, Vol.20 (1), p.207-208
Main Authors: Trovas, George, Tournis, Symeon
Format: Article
Language:English
Subjects:
Commentary
COVID-19 - complications
COVID-19 - prevention & control
Endocrinology
Humans
Medicine
Medicine & Public Health
Metabolic Diseases
SARS-CoV-2
Vitamin D - administration & dosage
Vitamin D - therapeutic use
Vitamin D Deficiency - complications
Vitamin D Deficiency - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections.
ISSN:1109-3099
2520-8721
DOI:10.1007/s42000-020-00231-9